BioNTech SE
Customers
0
None disclosed
Suppliers
2
0 disclosed
Latest period
Dec 31, 2024
10-K filed 2025-03-20
Suppliers 2
Companies that disclose BNTX as a major customer, as a share of their own revenue. 0 active, 2 lapsed.
| Company | % of their revenue | Est. $ from BNTX | Period | Trend | Status | Source |
|---|---|---|---|---|---|---|
| AUTL Autolus Therapeutics plc |
100% | $10.1M | FY 2024-12-31 | ±0.0pp | Lapsed Last seen 2024-12-31 |
10-K 2025-03-20 |
During the year ended December 31, 2024, 100% of the Company’s license revenues were generated from BioNTech. During the three and six months ended June 30, 2024, 100% of the Company’s license revenues were generated from BioNTech. During the three months ended March 31, 2024, 100% of the Company’s license revenues were generated from BioNTech. | ||||||
| MRVI MARAVAI LIFESCIENCES HOLDINGS, INC. |
34.8% | $307.3M | FY 2022-12-31 | +5.3pp | Lapsed Last seen 2022-12-31 |
10-K 2025-03-18 |
BioNTech SE * * 34.8 % * * BioNTech SE * 38.7 % * 37.2 % * 12.0 % BioNTech SE * 32.7 % * 36.7 % * 12.0 % BioNTech SE * 40.4 % * 12.0 % BioNTech SE * 34.8 % 29.5 % * 12.0 % BioNTech SE 38.7 % 26.2 % 37.2 % 32.2 % 21.6 % * BioNTech SE 32.7 % 44.8 % 36.7 % 35.6 % * * BioNTech SE 40.4 % 22.2 % * * | ||||||
Alerts are coming
Get an email when BNTX's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.